
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Ageless Tastefulness: An Outline of Valuable Gemstones and Adornments - 2
Anger as German family business group opens talks with far-right AfD - 3
Did we start the fire? A 400,000-year-old hearth sparks new questions about human evolution - 4
Living Abroad: Social Inundation and Self-improvement - 5
Figure out how to Use Your Brain research Degree in the Gig Market
'Here we go again': Businesses grapple with fuel costs
10 Delectable Specialty Mixed drinks
One perk to marrying Richard Marx later in life? 'We don't have time' for stupid arguments, says Daisy Fuentes.
Posts falsely claim Malaysian minister to relocate public hospital for temple
What's going around right now? COVID, flu, stomach bug on the rise
Hitler's madcap mega-railway would have linked Berlin with India
Iran fires one of largest barrages in weeks ahead of Passover
Dick Van Dyke shares his secrets to longevity as he turns 100
At least 36 dead in major fire in Hong Kong residential blocks













